[1]谭庆玲,张惠,陈碧玲.多囊卵巢综合征患者肾上腺雄激素水平与胰岛素抵抗的关系[J].国际放射医学核医学杂志,2011,35(6):358-361.[doi:10.3760,cma.j.issn.1673-4114.2011.06.009]
 TAN Qing-ling,ZHA NG Hui,CHEN Bi-lin.The relationship of adrenal androgen level and insulin resistance in polycystic ovary syndrome patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):358-361.[doi:10.3760,cma.j.issn.1673-4114.2011.06.009]
点击复制

多囊卵巢综合征患者肾上腺雄激素水平与胰岛素抵抗的关系(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
35
期数:
2011年第6期
页码:
358-361
栏目:
实验核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The relationship of adrenal androgen level and insulin resistance in polycystic ovary syndrome patients
作者:
谭庆玲 张惠 陈碧玲
湖北民族学院附属民大医院核医学科, 恩施 445000
Author(s):
TAN Qing-ling ZHA NG Hui CHEN Bi-lin
Department of Nuclear Medwine, Affiliated Hospital of Hubei Institute for Nationalities, Enshi 445000, China
关键词:
多囊卵巢综合征放射免疫分析肾上腺皮质激素类胰岛素抗药性
Keywords:
Polycystic ovary syndromeRadioimmunoassayAdrenal cortex hormonesInsulin resistance
DOI:
10.3760,cma.j.issn.1673-4114.2011.06.009
摘要:
目的 探讨多囊卵巢综合征(PCOS)患者肾上腺源性雄激素水平与胰岛素抵抗的关系。方法 对22名正常女性和85例PCOS患者行促肾上腺皮质激素(ACTH)兴奋试验,将PCOS患者分为高反应组(HR-PCOS)和正常反应组(NR.PCOS)。用放射免疫分析法检测血清促黄体生成素与卵泡刺激素(LH/FSH)比值、雌二醇、睾酮、孕酮,测定ACTH兴奋试验前后(0 min和60 min)血清17-羟孕酮(17-OHP)、硫酸脱氢表雄酮(DHEAS)、雄烯二酮(AD)、皮质醇,测定稳态模型下胰岛素抵抗指数(HOMA-IR),测量体质量指数(BMI)、腰臀围比。结果 在85例PCOS患者中,有20例的17-OHP水平高于正常,为HR-PCOS组,其余65例反应正常,为NR-PCOS组。基本情况比较:HR-PCOS组和NR.PCOS组的MBI及腰臀围比均显著高于对照组(MBI:χ2=13.874,14.512,腰臀围比:χ2=12.607,15.153,P均<0.05),HR-PCOS组和NR-PCOS组间差异无统计学意义(χ2=4.801,5.362,P>0.05);激素水平比较:HR-PCOS组和NR-PCOS组的LH/FSH比值、雌二醇显著高于对照组(LH/FSH:)(χ2=18.226,16.327,雌二醇:χ2=17.334,19.261,P均<0.01),HR-PCOS组和NR-PCOS组间差异无统计学意义;HR-PCOS组血清总睾酮显著高于NR-PCOS组(χ2=12.274,P<0.05),HR-PCOS组和NR-PCOS组均高于对照组(χ2=20.314,18.492,P均<0.01);ACTH兴奋试验前后HR-PCOS组17-OHP和DHEAS显著高于NR-PCOS组和对照组(17-OHP:χ2=18.063,19.214,DHEAS:χ2=17.358,19.355,P均<0.01),而NR-PCOS组与对照组间差异无统计学意义(χ2=4.109,4.362,P均>0.05);AD在ACTH兴奋试验前后HR-PCOS组和NR-PCOS组均高于对照组(χ2=14.062,16.549,P均<0.05),而HR-PCOS组和NR-PCOS组间差异无统计学意义(χ2=5.541,P>0.05);血清皮质醇在ACTH兴奋试验前后各组间差异无统计学意义;HR-PCOS组和NR-PCOS组的HOMA-IR均显著高于对照组(χ2=19.263,21.482,P均<0.01),且HR-PCOS组显著高于NR-PCOS组(χ2=13.582,P均<0.05)。结论 部分PCOS患者存在肾上腺雄激素亢进并对ACTH反应性增强,其肾上腺雄激素的水平可能与胰岛素抵抗有关。
Abstract:
Objective To investigate the relationship between adrenal androgen level and insulin resistance in polycystic ovary syndrome (PCOS) patients.Method Twenty-two heMthy women and 85 PCOS patients were underwent adrenocortieptropic hormone (ACTH) stimulation test,and 85 PCOS patients were divided into high response-polycystic ovary syndrome (HR-PCOS) group and normal response-polycystic ovary syndrome (NR-PCOS) group.The ratio of serum luteinizing hormone to follicle stimulating hormone (LH/FSH),estradiol (E2),testosterone (T) and pmgestin (P) were tested by radioimmunoassay method.17-hydroxy-progesterone (17-OHP),dehydroepiandros-teronesulfate (DHEAS) and andmsterone (AD) was tested at 0 and 60 min after an ACTH stimulation test.Body mass index (BMI),waist-to-hip-circumference radio (WHR) and homeostasis modes of assessment for insulin resistence index (HOMA-IR) were also measured.Results There were 20 cases that 17-OHP levels were higher than normal (HR-PCOS).the other 65 cases were NR-PCOS group.MBI and WHR (MBI:χ2=13.874,14.512,WHR:χ2=12.607,15.153,P all<0.05) of HR-PCOS group and NR-PCOS group were significantly higher than control group,but there had no significant difference between the two PCOS groups (χ2=4.801,5.326,P all>0.05).HR-PCOS group and NR-PCOS group were significantly higher than the control group for LH/FSH and estradiol(LH/FSH:χ2=18.226,16.327,E2:χ2=17.334,19.261,P all<0.05),but there had no significant difference between the two PCOS groups.Serum T of HR-PCOS group was significantly higher than control group(χ2=12.274,Pχ2=20.314,18.492,P all<0.01).17-OHP and DHEAS of HR-PCOS group were significantly higher than NR-PCOS group and control group before and after ACTH stimulation test (17-OHP:χ2=18.063,19.214,DHEAS:χ2=17.358,19.355,P all<0.01).But there had no differences between NR-PCOS group and control group(χ2=4.109,4.362,P all>0.05).AD of HR-PCOS group and NR-PCOS group were higher than control group before and after the ACTH stimulation test(χ2=14.062,16.549,P all<0.05).However, there had no differences (χ2=5.541,P>0.05)between the two PCOS groups.Serum cortisol was no difference between HR-PCOS,NR-PCOS and control groups before and after stimulation test.HOMA-IR of HR-PCOS group and NR-PCOS group were higher than control group(χ2=19.263,21.482,P all<0.01),and HR-PCOS group is higher than NR-PCOS group (χ2=13.582,P<0.05).Conclusions There have significantly higher basal and ACTH-stimulated level of adrenal androgen hyperresponsiveness in PCOS patients.Adrenal androgen level appears to be closely associated with insulin resistance in PCOS patients.

参考文献/References:

[1] Kumar A,Woods KS,Bartulucci AA,et al.Prevalence of adrenal andmgen excess in patients with the polycystie ovary syndrome (PCOS).Clin Endocrinol (Oxf),2005,62(6):644-649.
[2] Rotterdam ESHRF/ASRM-Sponsored PCOS Consensus work-shop Group.Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystie ovary syndrome.Fertil Steril,2004.81(2):19-25.
[3] Yildiz BO,Azziz R.The adrenal and polyeystic ovary syndrome.Rev Endocr Metab Disord,2007,8(4):331-342.
[4] Ehrmann DA.Polycystic ovary syndrome.N Engl J Med,2005,352(4):1223-1236.
[5] New MI,Lorensen F,lerner AJ,et al.Genotyping steroid 21-hy-droxylase deficiency:hormonal reference data.J Clin Endocrinol Metab,1983,57(2):320-326.
[6] 韩晓芬,钟雪梅.多囊卵巢综合征胰岛素抵抗的研究进展.西南军医,2009,11(1):76-78.
[7] 陶驶,刘伟,杨洁谨,等.多囊卵巢综合征患者下丘脑-垂体-肾上腺轴改变与胰岛素抵抗的关系.中华内分泌代谢杂志,2010,26(5):368-369.
[8] Vrbikova J,Hill M,Dvorakova K,et al.Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome.Gynecol Obstet Invest,2004,58(1):36-41.
[9] Guido M,Romualdi D,Suriano R,et al.Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polyeystic ovary syndrome.Hum Reprod,2004,19(3):534-539

相似文献/References:

[1]朱文茹,左书耀.瘦素的表达与肿瘤的关系[J].国际放射医学核医学杂志,2005,29(4):164.
 ZHU Wen-Ru,ZUO Shu-Yao.Relationship between leptin expression and tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):164.
[2]庞华.标记免疫分析技术及其进展[J].国际放射医学核医学杂志,2002,26(5):213.
 PANG Hua.Present situation and progress of labelling immunoassay[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(6):213.
[3]赵明辉.瘦素应用于肥胖症研究[J].国际放射医学核医学杂志,2001,25(5):193.
 ZHAO Ming-hui.Studies on leptin utilizing to obesity[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(6):193.
[4]韩佩珍.化学发光免疫分析[J].国际放射医学核医学杂志,2000,24(5):196.
 HAN Pei-zhen.Chemiluminescence immunoassay[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(6):196.

备注/Memo

备注/Memo:
收稿日期:2011-07-29。
通讯作者:谭庆玲(Email:tanqingling1972@126.com)
更新日期/Last Update: 1900-01-01